GSK

GSK plc NYSE

Healthcare ·Drug Manufacturers - General ·GB · gsk.com

$51.61

After hrs $50.90 +0.00%

Mkt Cap $106.2B

52w Low $35.45 61.6% of range 52w High $61.70

50d MA $56.04 200d MA $47.86

P/E (TTM) 18.7x

EV/EBITDA 7.6x

P/B 6.5x

Debt/Equity 1.1x

ROE —

P/FCF 12.7x

RSI (14) —

ATR (14) —

Beta 0.35

50d MA $56.04

200d MA $47.86

Avg Volume 5.3M

About

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, …

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Apr 29, 2026	TNS	1.16	1.24	+6.9%	51.40	+1.0%	+1.8%	+0.4%	—	—	—	—	—
Feb 4, 2026	TNS	0.64	0.68	+6.2%	57.23	+1.0%	+3.4%	+5.2%	+3.1%	+2.8%	+2.2%	-4.8%	—
Oct 29, 2025	TNS	1.26	1.48	+17.5%	45.93	+0.0%	+2.2%	+2.0%	+0.9%	+1.9%	+1.7%	+4.2%	—
Jul 30, 2025	TNS	—	0.96	—	38.97	-3.9%	-4.7%	-3.6%	-3.3%	-4.2%	-5.7%	+1.8%	—
Apr 30, 2025	TNS	1.08	1.13	+4.6%	39.85	-1.1%	-2.8%	-2.0%	-2.5%	-5.9%	-6.7%	+3.0%	—
Feb 5, 2025	TNS	0.44	0.59	+34.1%	37.70	-0.5%	-3.5%	-4.4%	-3.3%	-4.3%	-4.2%	+6.2%	—
Oct 30, 2024	TNS	1.16	1.27	+9.5%	37.01	-2.0%	-0.7%	-0.4%	-0.1%	+0.0%	-3.0%	-7.8%	—
Jul 31, 2024	TNS	1.00	1.09	+9.0%	38.77	+0.3%	+2.2%	+4.3%	+1.6%	-0.2%	+1.5%	+13.3%	—
Jan 31, 2024	TNS	0.76	0.72	-5.3%	39.44	+1.3%	+3.0%	+3.2%	+5.4%	+5.9%	+6.5%	+6.6%	—
Nov 1, 2023	TNS	1.09	1.26	+15.6%	34.58	-1.7%	-1.2%	-0.4%	+0.6%	+1.2%	+1.4%	+5.8%	—
Jul 26, 2023	TNS	0.87	0.97	+11.5%	35.87	+1.0%	+0.0%	-1.2%	-0.8%	-2.6%	-3.5%	-3.1%	—
Apr 26, 2023	TNS	0.82	0.90	+9.8%	35.93	+0.3%	+0.2%	+0.3%	+0.8%	+1.2%	+2.5%	-4.7%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Jan 6	Barclays	Downgrade	Equal Weight → Underweight	—	$49.02	$50.69	+3.4%	+3.1%	+3.3%	+2.4%	+2.8%	+2.8%
Nov 12	Jefferies	Downgrade	Buy → Hold	—	$36.35	$35.50	-2.3%	-2.3%	-3.4%	-5.4%	-8.3%	-7.3%
Oct 31	Guggenheim	Downgrade	Buy → Neutral	—	$37.01	$36.27	-2.0%	-0.7%	-0.4%	-0.1%	+0.0%	-3.0%
Jul 8	UBS	Downgrade	Buy → Neutral	—	$38.84	$38.85	+0.0%	-0.3%	-0.6%	-0.7%	+0.2%	+0.8%
Jul 2	Jefferies	Maintains	Buy → Buy	—	$38.38	$38.11	-0.7%	-0.4%	+0.2%	+1.2%	+0.9%	+0.6%
Mar 4	Guggenheim	Upgrade	Neutral → Buy	—	$42.03	$42.04	+0.0%	+1.0%	+1.4%	+1.4%	+3.7%	+2.6%
Jan 3	Jefferies	Upgrade	Hold → Buy	—	$37.51	$38.11	+1.6%	+3.8%	+4.2%	+4.5%	+5.7%	+6.0%
Feb 11	DZ Bank	Downgrade	Buy → Hold	—	$44.44	$44.37	-0.2%	-0.3%	-3.5%	-1.8%	-2.4%	-2.5%
Nov 5	Barclays	Upgrade	Underweight → Equal Weight	—	$43.00	$43.00	+0.0%	+1.1%	-0.5%	-0.6%	+0.4%	+0.5%
Mar 23	SVB Leerink	Downgrade	Outperform → Market Perform	—	$36.67	$36.25	-1.1%	-1.9%	-2.2%	-1.6%	+0.0%	+0.1%
Feb 4	Deutsche Bank	Downgrade	Hold → Sell	—	$35.42	$35.74	+0.9%	-0.1%	-0.5%	+0.1%	+0.9%	+0.3%
Jan 15	Deutsche Bank	Maintains	Hold → Hold	—	$38.16	$38.41	+0.7%	+0.8%	+1.0%	-0.4%	-1.0%	+0.5%
Nov 21	UBS	Upgrade	Neutral → Buy	—	$43.92	$43.99	+0.2%	+0.3%	+0.2%	+1.3%	+2.0%	+3.5%
Nov 11	Argus	Maintains	Buy → Buy	—	$44.42	$44.03	-0.9%	-0.4%	+0.2%	+0.5%	-1.3%	-0.7%
Oct 16	New Street	Upgrade	Reduce → Hold	—	$42.27	$42.45	+0.4%	+0.0%	+0.5%	+0.6%	+0.8%	+0.6%
Oct 11	Cantor Fitzgerald	Upgrade	Hold → Buy	—	$42.25	$42.15	-0.2%	-0.2%	-0.2%	+0.0%	+0.1%	+0.5%
Sep 3	Societe Generale	Upgrade	Sell → Buy	—	$41.58	$41.81	+0.6%	+2.0%	+1.9%	+1.3%	+1.2%	-0.2%
Jan 14	Exane BNP Paribas	Downgrade	Outperform → Neutral	—	$39.38	$38.73	-1.7%	-2.0%	-0.8%	-2.5%	-1.0%	-0.8%
Dec 14	Morgan Stanley	Maintains	Underweight → Underweight	—	$37.94	$37.58	-0.9%	-0.9%	-2.3%	-2.2%	-1.4%	-0.1%
Dec 14	SunTrust Robinson Humphrey	Maintains	Hold → Hold	—	$37.94	$37.58	-0.9%	-0.9%	-2.3%	-2.2%	-1.4%	-0.1%
Dec 6	Barclays	Downgrade	Overweight → Equal Weight	—	$38.34	$37.00	-3.5%	-2.4%	-2.7%	-1.7%	-2.6%	-1.7%
Aug 20	Argus	Maintains	Buy → Buy	—	$41.25	$41.21	-0.1%	+0.2%	+0.6%	+0.7%	-0.2%	+0.1%
May 5	Argus	Maintains	Buy → Buy	—	—	—	—	—	—	—	—	—
May 5	Argus	Upgrade	Hold → Buy	—	—	—	—	—	—	—	—	—
Oct 26	Bank of America	Downgrade	Buy → Neutral	—	$38.19	$37.29	-2.4%	-4.2%	-5.1%	-3.9%	-4.6%	-5.2%
Jul 5	Citigroup	Downgrade	Buy → Neutral	—	$42.77	$42.35	-1.0%	-0.3%	-1.2%	-1.2%	-1.3%	-1.8%
Sep 23	PiperJaffray	Maintains	Overweight → Overweight	—	$43.58	$43.20	-0.9%	-0.4%	-1.4%	-0.6%	+0.2%	-1.6%
Sep 14	Exane BNP Paribas	Downgrade	Neutral → Underperform	—	$42.51	$43.01	+1.2%	+1.5%	+2.4%	+0.9%	+1.9%	+1.3%
Aug 12	Argus	Maintains	Buy → Buy	—	$44.39	$44.45	+0.1%	-0.5%	+0.0%	-0.2%	+0.0%	+0.2%
Jul 14	Jefferies	Upgrade	Hold → Buy	—	$43.75	$44.13	+0.9%	+0.3%	+0.4%	+1.1%	-0.1%	+0.8%
Feb 26	Cantor Fitzgerald	Maintains	Hold → Hold	—	$39.50	$39.32	-0.5%	-0.9%	-2.1%	+0.4%	-0.3%	-0.8%
Jan 27	Bryan Garnier	Upgrade	Neutral → Buy	—	$40.83	$41.05	+0.5%	-0.6%	-0.5%	+1.1%	+1.3%	+0.2%
Oct 20	Credit Suisse	Upgrade	Underperform → Neutral	—	$41.74	$41.94	+0.5%	-1.4%	-2.1%	-0.7%	+0.9%	+0.8%
Oct 12	JP Morgan	Upgrade	Underweight → Neutral	—	$40.22	$40.00	-0.5%	+0.4%	-0.3%	+1.0%	+3.3%	+4.3%
Jun 4	Morgan Stanley	Downgrade	Overweight → Equal Weight	—	$44.03	$43.60	-1.0%	-2.0%	-3.3%	-4.1%	-4.2%	-2.5%
Jul 28	Mainfirst	Maintains	Underperform → Underperform	—	$48.60	$48.67	+0.1%	-0.8%	-1.2%	-0.3%	-0.5%	-1.2%
Apr 23	Argus	Upgrade	Hold → Buy	—	$55.30	$55.50	+0.4%	-0.3%	+0.4%	+0.8%	+1.3%	+2.0%
Apr 22	Panmure	Upgrade	Hold → Buy	—	$53.12	$55.52	+4.5%	+4.1%	+3.8%	+4.5%	+5.0%	+5.4%
Jan 27	S&P Capital IQ	Upgrade	Sell → Hold	—	$53.33	$53.38	+0.1%	-0.4%	-0.1%	-2.4%	-2.6%	-3.4%
Jan 24	Berenberg	Downgrade	Buy → Hold	—	$54.90	$54.02	-1.6%	-2.9%	-3.3%	-3.0%	-5.2%	-5.4%
Jan 22	Cowen & Co.	Downgrade	Outperform → Market Perform	—	$54.95	$55.00	+0.1%	-0.4%	-0.1%	-2.9%	-3.3%	-3.1%
Jan 9	UBS	Maintains	Neutral → Neutral	—	$52.73	$53.27	+1.0%	+0.2%	+0.0%	-1.6%	-0.3%	+1.2%
Dec 17	Deutsche Bank	Downgrade	Buy → Hold	—	$51.89	$51.07	-1.6%	-1.6%	-1.1%	-0.6%	-1.0%	-0.6%
Nov 12	Panmure	Downgrade	Buy → Hold	—	$53.03	$52.01	-1.9%	-1.6%	-2.1%	-1.7%	-1.8%	-1.9%
Oct 10	Credit Suisse	Downgrade	Neutral → Underperform	—	$49.31	$49.01	-0.6%	+0.8%	+1.0%	+2.1%	+1.6%	+2.0%
Oct 8	MainFirst	Upgrade	Underperform → Outperform	—	$50.13	$49.94	-0.4%	-1.2%	-1.6%	-0.9%	-0.7%	+0.4%
Sep 16	Barclays	Downgrade	Overweight → Equal Weight	—	$51.41	$51.87	+0.9%	-0.2%	-0.5%	-0.3%	-2.2%	-1.7%
Aug 21	Cowen & Co.	Upgrade	Market Perform → Outperform	—	$51.85	$52.17	+0.6%	+0.0%	+0.4%	+0.7%	+0.6%	-0.2%
Aug 15	Morgan Stanley	Downgrade	Equal Weight → Underweight	—	$51.92	$51.35	-1.1%	-0.8%	-0.6%	-1.2%	-0.1%	-0.1%
Aug 14	JP Morgan	Upgrade	Underweight → Neutral	—	$52.01	$52.35	+0.7%	-0.2%	-0.9%	-0.7%	-1.3%	-0.3%

Data updated apr 26, 2026 10:46am · Source: massive.com